Cite
Singapore tuberculosis (TB) clinical management guidelines 2024: A modified Delphi adaptation of international guidelines for drug-susceptible TB infection and pulmonary disease.
MLA
Teng, Ang Michelle Lay, et al. “Singapore Tuberculosis (TB) Clinical Management Guidelines 2024: A Modified Delphi Adaptation of International Guidelines for Drug-Susceptible TB Infection and Pulmonary Disease.” Annals of the Academy of Medicine, Singapore, vol. 53, no. 3, Mar. 2024, pp. 170–86. EBSCOhost, https://doi.org/10.47102/annals-acadmedsg.2023391.
APA
Teng, A. M. L., Chan Si Min, Cheng Lionel Tim-Ee, Cheong Hau Yiang, Chew Ka Lip, Maciej, C. P., Hsu Li Yang, Kaw Gregory Jon Leng, Kee Adrian Chin Leong, Ng Mark Chung Wai, Ong Rick Twee Hee, Ong Catherine Wei Min, Lishan, Q. J., D, O. B. S., Sng Li Hwei, Tan Jamie Bee Xian, Tan Cher Heng, Tay Jun Yang, Teo Lynette Li San, & Thoon Koh Cheng. (2024). Singapore tuberculosis (TB) clinical management guidelines 2024: A modified Delphi adaptation of international guidelines for drug-susceptible TB infection and pulmonary disease. Annals of the Academy of Medicine, Singapore, 53(3), 170–186. https://doi.org/10.47102/annals-acadmedsg.2023391
Chicago
Teng, Ang Michelle Lay, Chan Si Min, Cheng Lionel Tim-Ee, Cheong Hau Yiang, Chew Ka Lip, Chlebicki Piotr Maciej, Hsu Li Yang, et al. 2024. “Singapore Tuberculosis (TB) Clinical Management Guidelines 2024: A Modified Delphi Adaptation of International Guidelines for Drug-Susceptible TB Infection and Pulmonary Disease.” Annals of the Academy of Medicine, Singapore 53 (3): 170–86. doi:10.47102/annals-acadmedsg.2023391.